Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move

investors.com/news/technology/tempus-ai-stock-fda-clearance-tempus-pixel

Tempus AI stock jumped into a profit-taking zone Thursday after the FDA cleared its updated cardiac-imaging platform, Tempus Pixel.
The post Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-09-11 15:09:30.
The Entire Business World on a Single Page. Free to Use →